Charlotte Janssen Announces Resignation as Independent Director of Metaguest.AI
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Charlotte Janssen today announced her resignation as an independent director of Metaguest.AI...
Day: July 17, 2026
Cherokee Federal Expands Customer Access Through NASA SEWP VI Award
Company earns position on NASA's premier government-wide acquisition contractTULSA, Okla., July 17, 2026 /PRNewswire/ -- Cherokee Federal, the federal contracting...
NYSE Content Update: AdvanCell Raises $315 Million to Fight Prostate Cancer
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, July 17, 2026 /PRNewswire/ -- The New York...
Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist
Caresyntax will design and operate a multi-phase real-world evidence program for Vector, culminating in a prospective comparative registry across a...
Zendo Exit Leaves Burning Man Harm Reduction Gap…New Temple of Harm Reduction Launches Urgent Fundraiser
SAN FRANCISCO, CA / ACCESS Newswire / July 17, 2026 / The Temple of Harm Reduction, a newly founded religious...
Real Game Used (OTC PINK:MDCE) Gains Momentum with New Automated Authentication Platform and Featured Items in Infinite Auctions
Strong Subsidiary Performance Underscores Medical Care Technologies' Diversified Revenue Model and AI Innovation MESA, AZ / ACCESS Newswire / July...
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp
Rhelion Life Sciences reflects the Company's evolution into a sharpened focused, science-driven life sciences platform dedicated to psychedelic drug discovery,...
Best Reading Glasses for Women (2026): EZContacts Recognized for Style, Comfort, and Value by Expert Consumers
NEW YORK, July 17, 2026 /PRNewswire/ -- Expert Consumers has recognized EZContacts in its review of the Best Reading Glasses...
Best Prescription Glasses Brands Online in 2026: Why Quay Is Gaining Attention for Affordable and Stylish RX Frames According to Expert Consumers
NEW YORK, July 17, 2026 /PRNewswire/ -- Expert Consumers has recognized Quay for its growing presence in the online prescription...
Orion Group Half-Year Financial Report January–June 2026
ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2026 17 JULY 2026 at 12:00 EEST Orion Group Half-Year Financial Report January–June 2026 April–June...
Orion Corporation’s financial reporting and Annual General Meeting in 2027
ORION CORPORATION STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR 17 JULY 2026 at 10.30 EEST Orion Corporation’s financial reporting and Annual General...
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist...
European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU
Boehringer headquarters Boehringer headquarters, Ingelheim, Germany Not intended for UK and US audiences JASCAYD® (nerandomilast) is the first oral, preferential PDE4B...
Enjoin Reports 923% Average ROI Delivered in Q1 2026
Photo Courtesy of Enjoin NASHVILLE, Tenn., July 16, 2026 (GLOBE NEWSWIRE) -- Enjoin, a leading tech-enabled provider of Pre-Bill Chart...
Marketing Veteran Bryan Dulaney is advising SafeSpace Global on Growth Strategy
NASHVILLE, TN., July 16, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC), (“SafeSpace Global” or the “Company”), an AI-powered...
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in...
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven disorders Concurrent...
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
Transaction positions the combined company to execute a capital-efficient, repeatable strategy leveraging public market access and Lōkahi Therapeutics ai²-driven asset...
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
Trial court denied Company’s motion for a new trial and judgment as a matter of law for unjust enrichmentANI intends...
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
HONG KONG, July 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of...